Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $146K 950 sh |
| Jan 9, 2026 traded Jan 8, 2026 |
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $212K 1,417 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 6 | Reaume Marty MDirector | Option exercise · 10b5-1 plan | M | $90K 1,732 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 5 | Zedelmayer ChristineSr. Vice President and COO | Grant or award | A | — 500.0K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 5 | Carroll Hugh JDirector | Grant or award | A | — 1,200 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 5 | Cook Scott DDirector | Gift | G | — 30.8K sh | Jan 9, 2026 traded Jan 8, 2026 |
| 5 | Monroe Terilyn J.Chief People Officer | Open-market sale · 10b5-1 plan | SELL | $9,983 88 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 5 | Reaume Marty MDirector | Open-market sale · 10b5-1 plan | SELL | $37K 400 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 4 | Dines DanielDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $773K 45.0K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $103K 2,456 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $16K 100 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $39K 250 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $16K 100 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Williams Laura AChief Patient Officer | Option exercise · 10b5-1 plan | M | $50K 50.0K sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $16K 100 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $39K 250 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Lee Benjamin SeongChief Legal Officer | Option exercise · 10b5-1 plan | M | $221K 27.9K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $15K 100 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Lee Chan HenrySVP, General Counsel | Option exercise · 10b5-1 plan | M | $31K 196 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $15K 100 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $16K 100 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 1 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $53K 2,500 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 1 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $53K 2,500 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 1 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | $262K 25.2K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 55.6K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Lee Benjamin SeongChief Legal Officer | Option exercise · 10b5-1 plan | M | — 3,320 sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Lee Benjamin SeongChief Legal Officer | Option exercise · 10b5-1 plan | M | — 27.9K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 55.6K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Disposition to issuer · 10b5-1 plan | D | — 47.2K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Lee Chan HenrySVP, General Counsel | Option exercise · 10b5-1 plan | M | — 2,626 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 25.2K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 0 | Lee Chan HenrySVP, General Counsel | Option exercise · 10b5-1 plan | M | $39K 202 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 55.6K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 47.2K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Disposition to issuer · 10b5-1 plan | D | — 55.6K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Lee Benjamin SeongChief Legal Officer | Option exercise · 10b5-1 plan | M | $26K 3,320 sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Schwartz Richard ToddDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 47.2K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 0 | Lee Chan HenrySVP, General Counsel | Option exercise · 10b5-1 plan | M | — 3,458 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 0 | Williams Laura AChief Patient Officer | Option exercise · 10b5-1 plan | M | — 0 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 0 | Tom PennyPrincipal Accounting Officer | Grant or award · 10b5-1 plan | A | — 450.0K sh | Jan 9, 2026 traded Jan 7, 2026 |